Literature DB >> 28669066

Hypertension Survey in Italy: Novel Findings from the Campania Salute Network.

Eugenio Stabile1,2,3, Raffaele Izzo4,5, Francesco Rozza4,6, Maria Angela Losi4,6, Nicola De Luca4,5, Bruno Trimarco4,6.   

Abstract

The "Campania Salute" (CS) is a network system aimed at improving the management of essential hypertension by integrating the activity of general practitioners (GPs) with that of the hypertension specialists. It involves 23 outpatient hypertensive clinics distributed in different community hospitals of the Napoli's metropolitan area, 60 randomly selected GPs homogeneously distributed in the same area, and the Hypertension Clinic of the Federico II University in Naples (co-ordinating centre). Through the CS system it is possible to share clinical data collected during each visit at peripheral units (general practitioners and community hospitals hypertensive clinics), which manage low-risk hypertensive patients, and the co-ordinating centre, which mainly manages high-risk hypertensive patients. The co-ordinating centre works in co-operation with the peripheral units in the treatment and follow-up of all hypertensive patients. Since the first reports on the CS network activity, it has been evident the effectiveness of this network in ameliorating the clinical management of the hypertensive disease. CS network is also a large prospective registry that generated several scientific reports based on the longitudinal assessment of hypertensive patients during their treatment. Nowadays, as observed in the Health Search Database, the rate of BP control in Campania was 69.5%, almost reaching the "Objective 70%", a result that could be in part linked to the activity of the CS network.

Entities:  

Keywords:  Blood pressure; Hypertension; Observational study; Organ damage

Mesh:

Substances:

Year:  2017        PMID: 28669066     DOI: 10.1007/s40292-017-0220-5

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  50 in total

1.  Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.

Authors:  Raffaele Izzo; Maria-Angela Losi; Eugenio Stabile; Mai Tone Lönnebakken; Grazia Canciello; Giovanni Esposito; Emanuele Barbato; Nicola De Luca; Bruno Trimarco; Giovanni de Simone
Journal:  Hypertension       Date:  2016-11-28       Impact factor: 10.190

2.  Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; E J Roccella; D Levy
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

3.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

4.  Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database.

Authors:  G Tocci; G Nati; C Cricelli; D Parretti; F Lapi; A Ferrucci; C Borghi; M Volpe
Journal:  J Hum Hypertens       Date:  2016-09-15       Impact factor: 3.012

5.  Association of suboptimal blood pressure control with body size and metabolic abnormalities.

Authors:  Oreste Arcucci; Giovanni de Simone; Raffaele Izzo; Francesco Rozza; Marcello Chinali; Maria Assunta Elena Rao; Clara Bodenizza; Nicola De Luca; Bruno Trimarco
Journal:  J Hypertens       Date:  2007-11       Impact factor: 4.844

6.  Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study.

Authors:  David Conen; Paul M Ridker; Samia Mora; Julie E Buring; Robert J Glynn
Journal:  Eur Heart J       Date:  2007-10-09       Impact factor: 29.983

7.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors:  Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

8.  Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population.

Authors:  Athanase Benetos; Frédérique Thomas; Kathryn E Bean; Louis Guize
Journal:  J Hypertens       Date:  2003-09       Impact factor: 4.844

9.  Accuracy of telemedicine in detecting uncontrolled hypertension and its impact on patient management.

Authors:  Ahmed A Abdoh; Marie A Krousel-Wood; Richard N Re
Journal:  Telemed J E Health       Date:  2003       Impact factor: 3.536

10.  Hypertensive target organ damage predicts incident diabetes mellitus.

Authors:  Raffaele Izzo; Giovanni de Simone; Valentina Trimarco; Eva Gerdts; Renata Giudice; Olga Vaccaro; Nicola De Luca; Bruno Trimarco
Journal:  Eur Heart J       Date:  2013-07-23       Impact factor: 29.983

View more
  3 in total

1.  Low mechano-energetic efficiency is associated with future left ventricular systolic dysfunction in hypertensives.

Authors:  Maria V Manzi; Costantino Mancusi; Maria Lembo; Giovanni Esposito; Maria A E Rao; Giovanni de Simone; Carmine Morisco; Valentina Trimarco; Raffaele Izzo; Bruno Trimarco
Journal:  ESC Heart Fail       Date:  2022-04-28

2.  Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment.

Authors:  Michael T Eadon; Sri H Kanuri; Arlene B Chapman
Journal:  Expert Rev Precis Med Drug Dev       Date:  2018-01-03

3.  Determinants of improvement of left ventricular mechano-energetic efficiency in hypertensive patients.

Authors:  Maria Lembo; Valentina Trimarco; Maria Virginia Manzi; Costantino Mancusi; Giovanni Esposito; Salvatore Esposito; Carmine Morisco; Raffaele Izzo; Bruno Trimarco
Journal:  Front Cardiovasc Med       Date:  2022-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.